Human ARD1A (NAA10) activation kit by CRISPRa
CAT#: GA105457
NAA10 CRISPRa kit - CRISPR gene activation of human N(alpha)-acetyltransferase 10, NatA catalytic subunit
CNY 12255.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | NAA10 |
Locus ID | 8260 |
Kit Components | GA105457G1, ARD1A gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA105457G2, ARD1A gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA105457G3, ARD1A gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Reference Data | |
RefSeq | NM_001256119, NM_001256120, NM_003491 |
Synonyms | ARD1; ARD1A; ARD1P; DXS707; MCOPS1; NATD; OGDNS; TE2 |
Summary | N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN401354 | NAA10 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8680.00 |